Skip to content

Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach

Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02306707
Acronym
OERS
Enrollment
200
Registered
2014-12-03
Start date
2014-10-31
Completion date
2023-09-30
Last updated
2025-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma, Villous

Brief summary

A patient referred to have a lesion in the stomach removed. The aims of this study are to collect information on the technique of endoscopic removal of such lesions. By collecting information on a large number of patients undergoing this procedure the investigators can determine the best ways of diagnosing and removing these lesions safely and effectively.

Interventions

PROCEDUREEndoscopic Mucosal Resection

Sponsors

Professor Michael Bourke
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Stomach lesion \> 10mm * Lesion limited to the mucosal and/or submucosal layer (T1 lesion) * Aged 18 years or older

Exclusion criteria

* Lesion less than 10mm * Stomach lesion involves the muscularis propria (T2 lesion) on other staging modalities such as endoscopic ultrasonography (EUS) * Aged younger than 18 years

Design outcomes

Primary

MeasureTime frame
Observed procedural data: Number of Participants with Adverse Events as a Measure of Safety and Tolerability Outcomes14 days

Secondary

MeasureTime frameDescription
Analysis of the costs of this procedure compared to previous treatments14 daysPerform cost-utility analyses comparing different treatment approaches for stomach lesions

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026